BioSpace News Archive

Immatics Implements Genedata Biologics® into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR® Platform

Leading immuno-oncology company adopts Genedata Biologics® to support the discovery and development of TCRs for adoptive cell therapies and bispecific TCR molecules

November 13, 2019
·
3 min read
Genetown

Biopharma Commercial Leaders Share Views, Learn How TRINITY and TGaS® Combine Capabilities at Summit Event

The TGaS® Advisors 2019 Fall Summit, “Becoming Indispensable Business Partners: Overcoming Obstacles in Today’s Challenging Healthcare Environment,” brought together nearly 150 pharmaceutical professionals representing 66 companies.

November 13, 2019
·
7 min read
Business

Thomas Hecht to Chair Orion Biotechnology’s Board of Directors

Orion Biotechnology Canada Ltd. announced that Dr. Thomas Hecht has been appointed Chairman of its Board of Directors.

November 13, 2019
·
2 min read
Biotech Beach

Tracking and Delivering Targeted Cancer Therapeutics with Microbubbles and Sound Waves

Biomedical engineers at the University of Southern California developed a method using ultrasound to control and track drug release.

November 13, 2019
·
2 min read
·
Mark Terry
Drug Development

Kiadis to Restructure Months After Acquiring CytoSen Therapeutics

The company will discontinue development of its lead T-cell asset, ATIR101, halt its ongoing Phase III trial and lay off half its staff.

November 13, 2019
·
2 min read
·
Alex Keown
BioForest

Weill Neurohub Will Promote Cross-Institutional Collaboration in Brain Trauma and Neurodegenerative Diseases

The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift.

November 13, 2019
·
3 min read
·
Mark Terry
Is DNA the Data Storage of the Future?

DNA is structurally suited to storing information for extended periods of time, given its half-life of 521 years.

November 13, 2019
·
4 min read
·
David Kirk
Drug Development

GSK’s Nucala Hits the Mark in Phase III HES Trial, Setting Up Potential Approval

HES is a rare group of inflammatory disorders that affects approximately 20,000 people around the world.

November 13, 2019
·
2 min read
·
Alex Keown
Business

Abbott’s Miles White to Retire in 2020, COO Tapped as New CEO

Miles D. White will step down from his role as CEO following 21 years with the company. He will be succeeded by another long-time Abbott veteran, Robert B. Ford, who has been with the company for 23 years.

November 13, 2019
·
2 min read
·
Alex Keown
Career Advice

What Does an Employer Really Mean When Asking “Why Should We Hire You?”

“Why should we hire you?” is a question frequently asked in job interviews, but what’s really behind the question, and how should you respond to it?

November 13, 2019
·
4 min read
·
Katharine Hansen, PhD